Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-036416

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Apr 23, 2015S2,426$103.82D174,540D
Common stockF3,F4Apr 23, 2015S2,426$103.83D174,540ISee footnote
Common stockF5Apr 24, 2015S2,426$106.45D172,114D
Common stockF6,F4Apr 24, 2015S2,426$106.49D172,114ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses